Millennium Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Millennium Management LLC
CRD #158117
SEC #801-73884
CIK #0001426821, 0001605917, 0001273087, 0001446830
AUM 720.85 B (2026-03-31)
Employees 6,670 (46% Investors, 0% Brokers)
Phone212-841-4100
Address399 Park Avenue
New York, NY 10022
Source [IAPD] [EDGAR] [Website] [LinkedIn] [Instagram]
Total AUM ($B)
80064048032016002010201520212027
In the News
Fri, 24 Jul 2026 Millennium Management LLC Reduces Stake in Tenax Therapeutics Inc — GuruFocus
Fri, 24 Jul 2026 Millennium Management LLC Reduces Stake in Contineum Therapeutics Inc — GuruFocus
Wed, 22 Jul 2026 Millennium Management LLC Reduces Stake in Bleichroeder Acquisition Corp II — GuruFocus
Fri, 17 Jul 2026 Millennium Management LLC Reduces Stake in Elme Communities — GuruFocus
Fri, 17 Jul 2026 Millennium Management LLC Reduces Stake in Byrna Technologies Inc — GuruFocus
CIK Period
0001426821 0001605917 0001273087 0001446830
Sector Form 13F Holdings Value ($B)
Nvidia Corp 7.3
Apple Inc 4.7
Microsoft Corp 4.6
Facebook Inc 4.1
Amazon Com Inc 3.8
Tesla Motors Inc 3.1
Alphabet Inc 3.0
Broadcom Inc 2.1
Alphabet Inc 1.8
Advanced Micro Devices Inc 1.7
Micron Technology Inc 1.6
Discovery Communications Inc 1.4
Taiwan Semiconductor Manufacturing Co Ltd 1.4
Norfolk Southern Corp 1.3
Netflix Inc 1.2
Bank of America Corp /DE/ 1.0
Palantir Technologies Inc 1.0
Electronic Arts Inc 1.0
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold AUM
HF WMA Systematic Alpha Broad US Equity Return Master Fund LP [2026-02-03] 43.4 M
Filed 2026-01-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Large Cap Enhanced Equity Master Fund LP [2026-02-03] 299.1 M
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA International Ex-US Ex-HK Active Extension Master Fund LP [2025-09-30] 1,286.9 M
Filed 2025-08-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Active Extension Master Fund LP [2025-08-14] 2,752.4 M
Filed 2025-05-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA Global Large Cap Enhanced Equity Master Fund LP [2025-02-05] 378.3 M
Filed 2024-10-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA AE Institutional Fund I LP [2023-11-27] 400.5 M 917.6 M
Filed 2025-07-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA Systematic Equity Alpha Long/Short Master Fund LP [2023-02-27] 528.7 M 3,218.5 M
Filed 2025-05-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA International Equity 130/30 Master Fund LP [2019-02-20] 454.4 M 0.1 M
Filed 2020-12-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Equity 130/30 Master Fund LP [2019-02-20] 636.0 M 546.9 M
Filed 2021-12-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMQS Global Equity Active Extension Master Fund LP [2018-08-24] 1,277.9 M 12.76 B
Filed 2025-04-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 27 709.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 1.3
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 10.3
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 35 720.8
By Discretionary
Discretionary 35 720.8
Non-Discretionary 0 0.0
Total 35 720.8
By Non-United States Persons
Non-United States Persons 661.3
United States Persons 59.5
Total 35 720.8
Form D Directors Role # Filings # Firms 2011 - 2026
Ebony Myles-Berry Director 93 36
Ian Goodall Director 141 33
Michael McDonald Director 123 30
Robert Williams Executive Officer 30 3
Michael Gelband Executive Officer 9 3
Kevin Byrne Executive Officer 6 3
David Nolan Executive Officer 19 2
Israel Englander Executive Officer, Promoter 13 2
Simon Lorne Executive Officer 8 2
Igor Tulchinsky Promoter 8 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001273087]
3 [0001273087]
4 [0001273087]
SC 13G [0001273087]
13F-NT [0001426821]
3 [0001426821]
4 [0001426821]
3 [0001446830]
4 [0001446830]
D [0001605917]
Form 13D/13G Filer Form 13D/13G Subject Filed
Millennium Management LLC Perspective Therapeutics Inc [2026-07-20]
Millennium Management LLC Ares Acquisition Corp III [2026-07-07]
Millennium Management LLC Perspective Therapeutics Inc [2026-06-30]
Millennium Management LLC Maravai Lifesciences Holdings Inc [2026-06-29]
Millennium Management LLC Bellring Brands Inc [2026-06-29]
Millennium Management LLC Lenz Therapeutics Inc [2026-06-26]
Millennium Management LLC Xanadu Quantum Technologies Ltd [2026-06-25]
Millennium Management LLC DXC Technology Co [2026-06-24]
Millennium Management LLC Maravai Lifesciences Holdings Inc [2026-06-23]
Millennium Management LLC Relmada Therapeutics Inc [2026-06-22]
View All
Firm Profile (Form ADV)
Discretionary AUM$156.7B
ServesInstitutional
Fund TypesHedge Fund
LEI549300D0DN3CHSCJ0I36
Form 3/4/5 Subject 2011 - 2026
Faeth Therapeutics Inc
Englander Israel A
Millennium Management LLC
ICS Opportunities II LLC
Millennium Group Management LLC
CXApp Inc
ICS Opportunities Ltd
FiscalNote Holdings Inc
Megalith Financial Acquisition Corp
Integrated Core Strategies US LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
CXApp Inc CXAI
Class A Common Stock
2022-12-28 Other 175,000 $10.12 1,771,000
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-12-17 Sell 300,000 $9.87 2,961,000
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-11-12 Buy 30,681 $9.92 304,356
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-11-08 Buy 54,773 $9.92 543,348
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 209,699 $10.45 2,191,355
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 91 $10.50 956
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 189 $10.52 1,988
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 21 $10.55 222
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-17 Sell 216,200 $3.65 789,130
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-13 Sell 100,000 $3.71 371,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-13 Sell 100,000 $3.65 365,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-12 Sell 100,000 $3.58 358,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-11 Sell 100,000 $3.50 350,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-06 Sell 75,000 $3.53 264,750
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-05 Sell 100,000 $3.35 335,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-30 Sell 75,000 $3.27 245,250
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-28 Sell 100,000 $3.17 317,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-15 Sell 50,000 $3.15 157,500
Liberator Medical Holdings Inc LBMH
Common Stock
2014-06-27 Sell 100,000 $4.00 400,000
Liberator Medical Holdings Inc LBMH
Common Stock
2014-06-24 Sell 175,000 $4.05 708,750
showing 20 of 38 most recent transactions
Comparable Firms State AUM
BlackRock Advisors LLC
NY 1,096.12 B
Nomura Asset Management Co Ltd
601.79 B
Massachusetts Financial Services Company
MA 514.05 B
Arrowstreet Capital Limited Partnership
MA 351.32 B
Legal & General Investment Management America Inc
IL 267.16 B
Amova Asset Management Co Ltd
247.43 B
Two Sigma Investments LP
NY 232.82 B
Squarepoint Ops LLC
NY 226.98 B
Schonfeld Strategic Advisors LLC
NY 225.25 B
Rokos Capital Management LLP
219.44 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com